Diversification portfolio

Listed and diversified companies in the regions and leading sectors. They are leading companies in growth sectors, such as technology, pharma, biopharma and retail, and they generate long-term value.

Key data

5.4

€bn of asset value

17.8%

of GAV

GAV: Gross asset value (GAV)
Data as of 31 December 2024
€Bn = Billions

Within the
2025-2030
Strategic Plan

The diversification portfolio will be boosted by taking a stake in companies that have a growth strategy, as well as a recurring dividend. The plan aims to strengthen investment in this portfolio in sectors such as technology, pharma, biopharma and retail, reaching a value of 10 billion euros by 2030 (25% of total assets).